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Abstract 
 
Background/aims: Interactions between the autonomic nervous system (ANS) and the 
immune system functions in multiple sclerosis have been suggested. We aimed to evaluate the 
ANS dysfunction, more specifically postural orthostatic tachycardia (POTS), as a possible 
predictor of conversion to multiple sclerosis (MS) in patients with clinically isolated 
syndrome (CIS). 
 
Methods: In this observational, prospective, longitudinal study 84 patients were enrolled (56 
females, mean age 32.98.9). Disease activity during a six-month period was monitored 
(relapses and/or MRI disease activity indicated by new T2 or T1 enhancing lesions), and 
following predictors analyzed: age, EDSS, MRI midbrain, pontine or medulla oblongata 
lesions and POTS on the head up tilt test. 
 
Results: POTS was identified in 8 (9.5%) patients. Of 84 patients, 62 (73.8%) completed the 
six-month follow-up, and 28 (45.2%) patients converted to MS. Results of the multivariate 
regression analysis revealed age (10-year increase) and POTS as a significant predictors of 
early conversion to MS (OR 2.34, 95%CI 1.15 ± 4.78, p=0.019 and OR 12.40, 95%CI 1.13 ± 
136.62, p=0.040). The logistic model was statistically significant, χ2(6) = 13.885, p=0.031.  
 
Conclusion: POTS may be an indicator of a more active disease course in CIS patients and 
possibly be used as a prognostic factor.   
 
 
 
 
Key words: clinically isolated syndrome, multiple sclerosis, postural orthostatic tachycardia 
syndrome, autonomic nervous system 
  
Introduction 
 
We have recently shown that postural orthostatic tachycardia syndrome (POTS) is more 
prevalent in multiple sclerosis (MS) patients in comparison to patients with symptoms of 
orthostatic intolerance and no neurological illness [1]. Furthermore, it has been suggested that 
autonomic nervous system (ANS) dysfunction may contribute to MS inflammatory and 
neurodegenerative processes [2]. 
The aim of the present study was to evaluate the possible role of ANS dysfunction presenting 
as POTS as a predictor of conversion to MS in patients with clinically isolated syndrome 
(CIS).  
 
Methods 
 
Patients 
This was an observational, prospective, longitudinal study which included consecutive 
patients diagnosed with CIS from October 2014 until March 2016. The flowchart of the study 
is presented in Figure 1. Diagnosis of CIS was made in patients with acute or subacute 
development of neurological symptoms and/or signs lasting longer than 48 hours in the 
absence of fever or infection and with at least one demyelinating lesion larger than 3mm 
showing on brain and/or spinal cord MRI. MRI criteria for dissemination in time and space 
were reviewed as well and patients fulfilling the McDonald criteria at screening were 
excluded from the analysis [3]. The following parameters were collected during the baseline 
visit: age, expanded disability status scale (EDSS), presence of midbrain, pontine and medulla 
oblongata lesions on the baseline MRI.  
 
Autonomic nervous system testing 
ANS testing were performed in the Referral Center for Autonomic Nervous System 
Disorders, the only ANS center in Croatia by neurologists trained in ANS disorders. ANS 
testst included deep breathing test, heart rate and blood pressure response to Valsalva 
maneuver and 70° head-up tilt table test. The diagnosis of POTS was made if there was a 
sustained heart rate increment of ≥30 beats/minute during 10 min of head-up tilt, in absence 
of orthostatic hypotension (defined as a fall in blood pressure > 20/10 mm Hg) and absence of 
conditions such as, overt dehydration, substantial weight loss, or systemic illnesses, which 
could cause orthostatic intolerance [4]. If POTS was present, norepinephrine levels and 
Quantitative Sudomotor Axon Reflex Test (QSART) were performed in order to investigate 
peripheral autonomic dysfunction as a possible cause of POTS. 
 
Follow-up 
The patients were then followed for six months. Conversion to MS was defined as presence of 
one or both of the following parameters [3]:  
1. the patient developed second clinical attack  
2. one or more new T2 and/or gadolinium enhancing lesions on a follow-up MRI 
All baseline and follow-up MRIs were performed on a 1.5T MRI scanner. Analyzed MRI 
sequences included T2, FLAIR and T1 pre and postcontrast sequences. A neurologist with at 
least 5 years of experience with MS reviewed all MRIs. 
Following potential predictors were analyzed: age, EDSS, presence of midbrain, pontine and 
medulla oblongata lesions on the baseline MRI and presence of POTS.   
Ethical committees of the University Hospital Center Zagreb and University of Zagreb, 
School of Medicine approved the study. All participants signed informed consent. 
 
Statistical analysis 
Statistical analysis was performed using the IBM SPSS software, version 20. The 
Kolmogorov-Smirnov test was applied to test whether the data have a normal distribution. 
Differences in the distribution of qualitative variables were determined with the χ2 test, while 
the differences in quantitative variables, with respect to the distribution, were determined with 
the use of parametric t-test and non-parametric Mann-Whitney test. Multivariate logistic 
regression was used in order to determine which variables are significant predictors for 
specific model. P values less than 0.05 were considered as significant. 
 
 
Results  
 
Eighty-four CIS patients (56 females, mean age 32.98.9) were enrolled. Baseline patients’ 
characteristics are presented in Table 1. POTS was identified in 8 (9.5%) patients. Clinical 
symptoms, norepinephrine values and QSART results of POTS patients are presented in 
Table 2. There was no difference in age, EDSS, presence of midbrain, pontine and medulla 
oblongata lesions on the baseline MRI between patients with and without POTS (all p>0.05).   
Of the 84 patients, 62 (73.8%) completed the six-month follow-up and 28 (45.2%) patients 
converted to MS (Figure 1). There was no difference between patients who completed the six-
month follow-up and those who did not, regarding age, EDSS, presence of midbrain, pontine 
and medulla oblongata lesions on the baseline MRI, total number of T2 lesion on the baseline 
MRI and presence of POTS (2 POTS patients did not completed six-month follow-up) (all 
p>0.05). 
Results of the multivariate regression analysis revealed age (10-year increase) and POTS as 
significant predictors of early conversion to MS (Table 3). The logistic model was statistically 
significant, χ2(6) = 13.885, p=0.031. The presented model explained 26.8% (Nagelkerke R2) 
of the variance in conversion to MS. It correctly classified 71.0% of cases. 
 
 
Discussion 
 
This study has identified two risk factors for early conversion to MS within the first 6 months 
after CIS.  
The first one is age, with 10-year increase being associated with early conversion to MS. This 
finding is in contrast with previous studies showing the opposite, that younger age was 
associated with an increase in risk of a second clinical attack or conversion to MS [5,6]. 
However, these studies only used second clinical attack, and not MRI parameters of disease 
activity, as evidence of conversion to MS, which together with a small sample size may 
explain this discrepancy. 
The second risk factor is the presence of POTS, which is becoming recognized as one of the 
more frequent forms of orthostatic intolerance [7]. It has recently been shown that POTS is 
more frequent in MS patients in comparison to patients with symptoms of orthostatic 
intolerance and no neurological illness [1]. This observation is interesting from several 
aspects. MS and POTS share a similar age of onset, gender preponderance and several 
symptoms such as fatigue and dizziness. Furthermore, some studies suggest an autoimmune 
basis in some percentage of POTS patients [8]. Autonomic dysfunction is present in a 
substantial proportion of MS patients even at the beginning of the disease and studies suggest 
that the sympathetic and parasympathetic nervous systems occur with a different pattern in 
MS [9]. Initial sympathetic activation seems to be driven by MS clinical activity/relapses with 
a subsequent progressive sympathetic dysfunction. In contrast, parasympathetic dysfunction 
correlates with progression of clinical disability, resulting more likely from structural CNS 
damage in MS [10]. One of the suggested causes of POTS is centrally driven abnormal 
sympathetic activity and this could explain POTS in MS patients. This type of POTS is 
considered to be associated with values of standing NE higher than 3.5 nmol/L [11]. In our 
cohort two patients had standing NE values 3.5nmol/L, and none had evidence of 
neuropathy when inspected by QSART further indicating central cause of POTS in our cohort 
of CIS patients. However, QSART was available in only 5 out of 8 POTS patients and one 
had mild sudomotor dysfunction without any other evidence of small fiber neuropathy.  
Moreover, a close relationship between autoimmune and autonomic system has been 
suggested, in the way that pathologic interactions between them may fail to trigger anti-
inflammatory mechanisms, which are essential to prevent repeated inflammatory attacks, a 
key pathogenic feature of MS [12]. Furthermore, the finding that POTS occurs more 
frequently during relapse compared to remission in patients with relapsing remitting MS may 
indicate a connection between ANS dysfunction and disease activity [13]. Bearing this in 
mind, results in this study suggest that POTS in MS is associated with disease activity. 
Therefore, given the presented evidence one should consider that POTS in MS may be a 
reflection of disrupted autonomico-immunological interaction playing a role in the underlying 
mechanisms of the disease.     
Limitations of our study are a small cohort size and the fact that the MRI imaging protocols 
were not standardized. Furthermore, 26.2% patients did not complete the six-month follow-up 
mainly because MRI was not performed. However, we found no difference between all 
baseline characteristics between patients who did and those who did not completed the six-
month follow-up. The main strength of our study is that autonomic dysfunction has never 
been considered in prospective MS studies up to now and represents a good basis for future 
research.  
In conclusion, we found relatively high proportion of MS patients have POTS in the earliest 
stages of the disease. We also found that autonomic dysfunction presenting as POTS may be 
an indicator of a more active disease course and possibly be used as a prognostic factor. 
Considering the recent literature, which argues for a greater role of autonomic nervous system 
in MS, and the results presented here, further studies in this field are justified and desirable. 
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Table 1. Baseline characteristics. 
 
Baseline characteristic N=84 
Gender, N (%)  
Female 
Male 
56 (66.7%) 
28 (33.3%) 
Age, mean (SD) 32.9 (±8.9) 
CIS type, N (%)  
Optic neuritis 
Transverse myelitis 
Brainstem/cerebellum 
Hemispheric 
Multifocal 
25 (29.8%) 
25 (29.8%) 
24 (28.6%) 
8 (9.5%) 
2 (2.4%) 
EDSS, median (range) 1 (0-3.5) 
Midbrain MRI lesions, N (%)  
Present 
Absent 
9 (10.7%) 
75 (89.3%) 
Pontine MRI lesions, N (%)  
Present 
Absent 
29 (34.5%) 
55 (65.5%) 
Medulla oblongata MRI lesions, N (%)  
Present 
Absent 
11 (13.1%) 
73 (86.9%) 
POTS, N (%)  
Present 
Absent 
8 (9.5%) 
76 (90.5%) 
 
 
 
 
Table 2. Description of CIS patients who had POTS on head-up tilt table test. 
No. 
Type of 
CIS 
Supine Tilt-up 
QSART 
Reported symptoms of autonomic dysfunction 
E  NE  D  E  NE  D  
Orthostatic 
intolerance 
Vasomotor Secretomotor GI Bladder Pupillomotor 
1 H  0.15 1.39 0.38 0.11 2.99 0.20 normal - - - + - - 
2 BS  NA NA NA NA NA NA normal + - + + - + 
3 BS  0.082 0.26 0.20 0.29 1.45 0.50 normal - - + - - - 
4 TM  0.082 1.15 0.20 0.25 2.34 0.20 foot hypohidrosis + - - + - + 
5 BS  0.082 1.27 0.18 0.34 2.11 0.37 normal - - - + - - 
6 TM  0.22 5.06 NA 0.4 10.01 NA NA + + + + - + 
7 TM  0.17 1.18 0.2 0.36 2.7 0.3 NA - - - + - + 
8 M  0.16 3.32 0.64 0.24 3.81 0.2 NA + - - + - + 
H – hemispheric, BS – brainstem, TM – transverse myelitis, M – multifocal; GI – gastrointestinal, E – epinephrine (normal values <0.46 nmol/l), 
NE – norepinephrine (normal values <2.49 nmol/l); D - dopamine 
Table 3. Results of the multivariate regression analysis for predictors of early conversion to 
multiple sclerosis. 
Predictors OR 95%CI 
Age (10-year increase) 2.34 1.15 ± 4.78* 
EDSS 1.72 0.89 ± 3.31 
Midbrain lesions 1.36 0.22 ± 8.55 
Pontine lesion 0.64 0.16 ± 2.60 
Medulla oblongata lesions 3.20 0.45 ± 22.62 
POTS 12.40 1.13 ± 136.62* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 
 
Figure 1. Study flowchart. 
 
 
 
